These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34751132)

  • 21. Mycobacterium tuberculosis EsxO (Rv2346c) promotes bacillary survival by inducing oxidative stress mediated genomic instability in macrophages.
    Mohanty S; Dal Molin M; Ganguli G; Padhi A; Jena P; Selchow P; Sengupta S; Meuli M; Sander P; Sonawane A
    Tuberculosis (Edinb); 2016 Jan; 96():44-57. PubMed ID: 26786654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis.
    Zahrt TC; Deretic V
    Antioxid Redox Signal; 2002 Feb; 4(1):141-59. PubMed ID: 11970850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    Wade MM; Zhang Y
    J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    Lee HJ; Ko HJ; Kim SH; Jung YJ
    PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A self-assembled nanocompartment in anammox bacteria for resisting intracelluar hydroxylamine stress.
    Xing CY; Fan YC; Chen X; Guo JS; Shen Y; Yan P; Fang F; Chen YP
    Sci Total Environ; 2020 May; 717():137030. PubMed ID: 32062250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
    Heifets L; Higgins M; Simon B
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
    Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
    Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.
    den Hertog AL; Menting S; Pfeltz R; Warns M; Siddiqi SH; Anthony RM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4956-60. PubMed ID: 27270287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Defect in Autophagy Induction by Clinical Isolates of Mycobacterium Tuberculosis Is Correlated with Poor Tuberculosis Outcomes.
    Li F; Gao B; Xu W; Chen L; Xiong S
    PLoS One; 2016; 11(1):e0147810. PubMed ID: 26815035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs.
    Chung WJ; Kornilov A; Brodsky BH; Higgins M; Sanchez T; Heifets LB; Cynamon MH; Welch J
    Tuberculosis (Edinb); 2008 Sep; 88(5):410-9. PubMed ID: 18674969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nutrient starved incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis].
    Chen ZF; Huang Q; Li YY; Zhang Y; Ren Y; Li KS; Fu ZJ; Xu SQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 May; 30(5):359-62. PubMed ID: 17651643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.
    Somoskovi A; Parsons LM; Salfinger M
    Respir Res; 2001; 2(3):164-8. PubMed ID: 11686881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death.
    Peng X; Luo T; Zhai X; Zhang C; Suo J; Ma P; Wang C; Bao L
    Microb Pathog; 2019 Jan; 126():45-55. PubMed ID: 30366125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infection.
    Bhaskar A; Chawla M; Mehta M; Parikh P; Chandra P; Bhave D; Kumar D; Carroll KS; Singh A
    PLoS Pathog; 2014 Jan; 10(1):e1003902. PubMed ID: 24497832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action.
    Kim JJ; Lee HM; Shin DM; Kim W; Yuk JM; Jin HS; Lee SH; Cha GH; Kim JM; Lee ZW; Shin SJ; Yoo H; Park YK; Park JB; Chung J; Yoshimori T; Jo EK
    Cell Host Microbe; 2012 May; 11(5):457-68. PubMed ID: 22607799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.